Everest Medicines Funding: $360M Raised, Investors & Rounds

Everest Medicines is based in Shanghai, China. It has raised $360M in total funding.

Everest Medicines funding overview

Everest Medicines is based in Shanghai, China. Everest Medicines has raised $360M in total disclosed funding. That places its disclosed total in the $250M–$1B range.

Everest Medicines at a glance

Total raised
$360M
Headquarters
Shanghai, China

Frequently asked about Everest Medicines funding

How much has Everest Medicines raised?
Everest Medicines has raised $360M in total disclosed funding across the rounds on record.
Who has invested in Everest Medicines?
No investors are named on the public record for Everest Medicines yet.
What was the latest Everest Medicines funding round?
No round stage has been disclosed for Everest Medicines.
Where is Everest Medicines based?
Everest Medicines is based in Shanghai, China.

Round data for Everest Medicines is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

Companies related to Everest Medicines (18)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades